13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 48 holding rows worth $369,526,506.
- Accession
- 0001214659-24-014597
- Filer
- CIK 1482416
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 48 entries on the cover page, a total value of $369,526,506 stated on the cover page (in dollars after the unit check, H1), rows summing to $369,526,506 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,362,700 | $91,300,900 | dollars as filed | put |
| LABCORP HOLDINGS INC COM SHS | 504922105 | Stock | 245,902 | $50,043,516 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 111,078 | $23,363,036 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 155,304 | $16,855,143 | dollars as filed | |
| SMITH & NEPHEW PLC SPDN ADR NEW | 83175M205 | ADR | 579,619 | $14,362,959 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 455,500 | $13,031,855 | dollars as filed | put |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 608,096 | $12,587,587 | dollars as filed | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 312,000 | $12,012,000 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 225,165 | $10,188,716 | dollars as filed | |
| VAXART INC NEW | 92243A200 | COM | 14,764,991 | $9,852,678 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 600,294 | $9,598,701 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 89,500 | $9,299,945 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 26,786 | $8,854,648 | dollars as filed | |
| KENVUE INC | 49177J102 | COM | 485,000 | $8,817,300 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 192,000 | $8,653,440 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,874,536 | $6,783,905 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 4,347,855 | $6,652,218 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 510,267 | $4,643,430 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 71,740 | $4,568,403 | dollars as filed | |
| BAUSCH PLUS LOMB CORP | 071705107 | COMMON SHARES | 302,710 | $4,395,349 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,708,408 | $4,387,621 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 491,128 | $4,179,499 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 125,174 | $3,170,657 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 78,000 | $3,069,300 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,328,352 | $2,663,346 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 1,539,352 | $2,432,176 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 175,301 | $2,368,317 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 177,004 | $2,295,742 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 163,363 | $2,123,719 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 668,115 | $1,950,896 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 217,864 | $1,854,023 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 778,924 | $1,799,314 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 293,417 | $1,772,239 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 159,626 | $1,484,522 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 2,499,800 | $1,449,884 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 320,394 | $1,220,701 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 276,603 | $1,125,774 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 315,000 | $960,750 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 71,458 | $891,081 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 121,672 | $699,614 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 162,058 | $627,164 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 133,412 | $397,568 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 50,839 | $354,348 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $206,700 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 254,150 | $76,245 | dollars as filed | |
| Humacyte Inc W Exp 08/27/202 | 44486Q111 | SPAC Combination | 49,998 | $70,497 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 400,000 | $28,880 | dollars as filed | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 12,808 | $200 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-24-014597 | this filing | 2024-08-14 | acceptance time not in the bulk data set |